Clinical-radiomic model in advanced kidney cancer predicts response to tyrosine kinase inhibitors

Renal cancer has a global incidence and mortality of 2.2 and 1.8%, respectively. Up to 30% of these patients are intrinsically resistant to tyrosine kinase inhibitors (TKI). The National Comprehensive Cancer Network guidelines do not include any predictive factors regarding response to systemic ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Negreros-Osuna, Adrián A., Ramírez-Mendoza, Diego A., Casas-Murillo, Claudio, Guerra-Cepeda, Abraham, Hernández-Barajas, David, Elizondo-Riojas, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647788/
https://www.ncbi.nlm.nih.gov/pubmed/36420068
http://dx.doi.org/10.3892/ol.2022.13566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647788/
https://www.ncbi.nlm.nih.gov/pubmed/36420068
http://dx.doi.org/10.3892/ol.2022.13566

Ejemplares similares